Recognizing First Progression in Gastric Cancers

 

ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer
T

New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGFR2 Ramucirumab +/- Chemotherapy

By ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer FEATURING Tomislav Omrcen
By ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer FEATURING Tomislav Omrcen
216 views
November 28, 2019
0 Comments
Login to view comments. Click here to Login
Recognizing First Progression in Gastric Cancers
23:25
2nd Annual International Gastric Cancer Educational Symposium

Nutrition Care in Patients With GC: Recommendations During and After…

Feat. R. Lopez
24:50
UChicago Medicine

Optimizing 2/3L Therapy for GE Adenocarcinoma: RAINBOW Paclitaxel/Ra…

Feat. D. Catenacci
20:40
2nd Annual International Gastric Cancer Educational Symposium

Optimization of Perioperative Gastric Cancer Care: What Are the Outc…

Feat. A. Nagarajan
12:23
Afsaneh Barzi

RAINBOW & REGARD Trial Data on Gastric Cancer: The Impact of 2L …

16:00
2nd Annual International Gastric Cancer Educational Symposium

Genetic Testing in Gastric Cancer: How to Recognize Hereditary Cance…

Feat. S. Rhode
09:58
2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclita…

Feat. D. Catenacci
13:08
Gastroesophageal Cancer Educational Symposium

Prevention and Detection of Gastric Cancer: How Can We Detect It Ear…

Feat. A. Chan
09:03
Geoffrey Ku

Gastric Cancer Management: Why Is It Important to Actively Treat? Ho…

05:07
Zev A. Wainberg

Efficacy Data From RAINBOW Trial on Advanced Gastric Cancer: The Eff…

06:38
ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer

New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGF…

Feat. T. Omrcen
29:08
Gastroesophageal Cancer Educational Symposium

Nutrition Considerations for Gastroesophageal Cancer: Goals, How the…

Feat. A. Draviam
22:53
2nd Annual International Gastric Cancer Educational Symposium

Managing Hereditary Diffuse Gastric Cancer: Is Prophylactic Gastrect…

Feat. M. Burch
24:28
2nd Annual International Gastric Cancer Educational Symposium

Integrative Medicine for GC: What Is Integrative Oncology, and How t…

Feat. M. Cusnir
12:10
Shagufta Shaheen

Targeted and Novel Therapy in HER2+ Advanced Gastric Cancer: Efficac…

18:17
Shagufta Shaheen

2021 Update on HER2- Gastric Cancer: 1L Chemo + Nivo, Bemarituzumab …

11:02
Moffitt Cancer Center

Utilization of ctDNA NGS Analysis in Stage IV Cancers: PANGEA Strate…

Feat. D. Catenacci
21:00
Raul Gonzalez

Pathologist's Perspective on Targeted Therapies in Advanced Gas…

05:12
Bassel El-Rayes

Improving Survival in Advanced HER2+/- Gastric Cancer: Considering 2…

08:35
Fox Chase Cancer Center

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Feat. N. Vijayvergia
14:38
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Recent IO Data in GEJ or Gastric Cancers: Are We There Yet?

Feat. O. Alese
09:20
2021 KUMC Virtual Multidisciplinary Oncology Review

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bem…

Feat. A. Saeed
07:44
Memorial Sloan Kettering Cancer Center

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Feat. Y. Y. Janjigian
22:59
Mayo Clinic & DDF Gastroesophageal Cancer Educational Symposium

Understanding Genetic and Environmental Risk Factors in Gastroesopha…

Feat. L. Boardman
08:20
Massachusetts General Hospital Cancer Center

ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in …

Feat. S. Klempner